Delivery Order SPE2DE24D0013-SPE2D626F28A0
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $28,875 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRS-COV2-10, was issued with no set-aside designation and represents procurement of diagnostic testing supplies under Cepheid's existing Indefinite Delivery Contract framework with the Department of Veterans Affairs....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,040 delivery order (Contract No. 4570200483, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is for molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. The award represents a continuation of Cepheid's established...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $4,500 delivery order (contract number GXMRSA-NXG-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a continuation of the federal government's reliance on Cepheid's molecular diagnostic solutions. The place of performance is located in Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc. was awarded a firm fixed-price delivery order valued at $1,750 by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This delivery order, issued under contract GXMRSA-NXG-10, requires performance in Sunnyvale, California, where Cepheid maintains its headquarters. The contract contains no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 under a firm fixed-price contract by the Defense Logistics Agency Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, designated XPRS4PLEX-10, was issued with no set-aside designation and calls for the supply of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F28A0Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 firm fixed-price delivery order (Contract No. 4570311585, XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Contract (IDC) established with the Department of Veterans Affairs VISN 17, valued at $6.7 million through December 28, 2029. The contract calls for the provision of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform, specifically XPRS4PLEX-10 cartridges designed for detecting multiple respiratory pathogens. Performance will take place at Cepheid's facility in Sunnyvale, California. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems and reagents, serving multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competencies include rapid molecular diagnostic testing for infectious diseases such as COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions. Through its extensive portfolio of firm fixed-price contracts across the VA system, Cepheid supplies diagnostic equipment, reagents, test kits, and maintenance services to support clinical laboratory operations and infectious disease testing requirements across the distributed network of VA medical centers and integrated service networks nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/15/25 |